Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-04-26Triage Plus for TB: Improving Community-Based Provision for TB in Africa. The Impact of Involving Informal Health Providers for Tuberculosis Control in Sudan
-
CLINICAL_TRIALS study record update · 2013-04-26Efficacy and Safety of Immunomodulator (Mycobacterium w.) as an Adjunct Therapy in Category I Pulmonary Tuberculosis and Along With Assessment of Immunological Parameters
-
CLINICAL_TRIALS study record update · 2013-04-18Phase I, Open-label, 3-way Crossover Trial in Healthy Volunteers to Determine the Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.
-
CLINICAL_TRIALS study record update · 2013-03-06The Role of Routine Bacterial Culture Including Tuberculosis During
-
CLINICAL_TRIALS study record update · 2013-03-06Conversion Rate of TST and Quantiferon-TB Gold In Tube Assay in Health Care Workers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-02-20EVALUATION OF THE PERFORMANCE OF THE NITRATE REDUCTASE AND RESAZURIN TITRE ASSAY FOR THE DETECTION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX FROM SPUTUM IN A HIGH TB AND HIV SETTING
-
CLINICAL_TRIALS study record update · 2013-01-31Preliminary Field Evaluation of a Point-of-Care Transaminase Test
-
CLINICAL_TRIALS study record update · 2013-01-24Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2013-01-24Population Pharmacokinetics Analysis of Ethambutol in Overweight and Obese Volunteers
-
CLINICAL_TRIALS study record update · 2013-01-21A Safety and Dose Finding Trial of the Diagnostic Test C-Tb, When Given Intradermally by the Mantoux Technique to Adult Patients Recently Diagnosed With Active TB
-
CLINICAL_TRIALS study record update · 2013-01-21An Open Phase I Clinical Trial on the Safety and Risk of Sensitisation by Escalating Doses and Repeated Injections of the rdESAT-6 + rCFP-10 Skin Test Reagent Following Intradermal Administration to Healthy Adults
-
CLINICAL_TRIALS study record update · 2013-01-21A Safety and Immunogenicity Phase 1 Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31) Administered at 0 and 2 Months
-
CLINICAL_TRIALS study record update · 2013-01-21An Open Phase I, Dose-escalating, Clinical Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2013-01-21A Safety and Immunogenicity Phase 1 Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31)Administered in PPD Positive Volunteers at 0 and 2 Months
-
CLINICAL_TRIALS study record update · 2013-01-21A Phase IIa Specificity Trial of the Diagnostic Agent C-Tb, When Given Intradermally by the Mantoux Technique to Healthy Volunteers Previously Vaccinated With BCG
-
CLINICAL_TRIALS study record update · 2013-01-16The Pharmacogenetics of Vitamin D Supplementation in Tuberculosis
-
CLINICAL_TRIALS study record update · 2012-12-27The Application of the N-acetyltransferase 2 (NAT2) Genotyping in Re-challenge Protocol of Isoniazid (INH) Titration in Patients With Anti-TB Medications-induced Hepatitis
-
CLINICAL_TRIALS study record update · 2012-12-24A Randomised Control Trial of Sputum Induction, and New and Emerging Technologies in a High HIV Prevalence Primary Care Setting
-
CLINICAL_TRIALS study record update · 2012-12-17Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs
-
CLINICAL_TRIALS study record update · 2012-11-12Prophylactic Use of Entecavir to Reduce Hepatitis Flare in Highly Viremic HBV Patients With Active Tuberculosis Receiving Anti-tuberculous Treatment
-
CLINICAL_TRIALS study record update · 2012-10-22Novel TB Prevention Regimens for HIV-Infected Adults
-
CLINICAL_TRIALS study record update · 2012-10-17Effect of Rifampin-containing Anti-TB Treatment on Efavirenz Pharmacokinetics in HIV/TB Co-infected Children Aged 3 - 14 Years
-
CLINICAL_TRIALS study record update · 2012-10-12Effect of Rifampin-containing Anti-TB Therapy on Nevirapine Plasma Pharmacokinetics in HIV/TB Co-infected Children < 3 Years Old
-
CLINICAL_TRIALS study record update · 2012-10-11Pharmacokinetics and Safety of the WHO Recommended Increased Dosages of the First-line Anti-TB Medications in Children With TB and HIV/TB Coinfection
-
CLINICAL_TRIALS study record update · 2012-09-27TBTC Study 26: Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months Versus Daily Isoniazid for 9 Months for the Treatment of Latent Tuberculosis Infection